Lonestar Medicines, Inc.

Biotechnology company · Boston, Massachusetts, United States

Lonestar Medicines, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Lonestar Medicines at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2025

SEC CIK2111460

What does Lonestar Medicines do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $25 million sold (2026).

Frequently asked questions about Lonestar Medicines

Where is Lonestar Medicines headquartered?

Lonestar Medicines, Inc. is headquartered in Boston, Massachusetts, United States.

What does Lonestar Medicines do?

Lonestar Medicines, Inc. is a biotechnology company.

When was Lonestar Medicines founded?

The earliest incorporation on record for Lonestar Medicines, Inc. is in 2025, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences